157 related articles for article (PubMed ID: 29856361)
1. Lymphomatoid Granulomatosis with Isolated Cutaneous Lesions: Prolonged Remission After DA-EPOCH Protocol.
Gupta VG; Gogia A; Sharma V; Mallick S
Turk J Haematol; 2018 Aug; 35(3):213-214. PubMed ID: 29856361
[No Abstract] [Full Text] [Related]
2. Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial.
Melani C; Dowdell K; Pittaluga S; Dunleavy K; Roschewski M; Song JY; Calattini S; Kawada JI; Price DA; Chattopadhyay PK; Roederer M; Lucas AN; Steinberg SM; Jaffe ES; Cohen JI; Wilson WH
Lancet Haematol; 2023 May; 10(5):e346-e358. PubMed ID: 37011643
[TBL] [Abstract][Full Text] [Related]
3. Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas.
Roswarski J; Roschewski M; Lucas A; Melani C; Pittaluga S; Jaffe ES; Steinberg SM; Waldmann TA; Wilson WH
Leuk Lymphoma; 2018 Jun; 59(6):1466-1469. PubMed ID: 29032710
[No Abstract] [Full Text] [Related]
4. Lymphomatoid granulomatosis. Successful treatment with CHOP combination chemotherapy.
Drasga RE; Williams SD; Wills ER; Roth LM; Einhorn LH
Am J Clin Oncol; 1984 Feb; 7(1):75-80. PubMed ID: 6546471
[TBL] [Abstract][Full Text] [Related]
5. Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma.
Chihara D; Westin JR; Miranda RN; Cheah CY; Oki Y; Turturro F; Romaguera JE; Neelapu SS; Nastoupil LJ; Fayad LE; Rodriguez MA; Fowler NH; Orlowski RZ; Wang M; Hagemeister FB; Medeiros LJ; Fanale MA
Br J Haematol; 2017 Nov; 179(3):503-506. PubMed ID: 27378601
[No Abstract] [Full Text] [Related]
6. Syndrome of inappropriate antidiuretic hormone secretion associated with primary cutaneous anaplastic large cell lymphoma.
Hirata Y; Yokote T; Nishiwaki U; Tsuji M; Hanafusa T
Br J Haematol; 2012 May; 157(4):412. PubMed ID: 22409317
[No Abstract] [Full Text] [Related]
7. Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group.
Purroy N; Bergua J; Gallur L; Prieto J; Lopez LA; Sancho JM; García-Marco JA; Castellví J; Montes-Moreno S; Batlle A; de Villambrosia SG; Carnicero F; Ferrando-Lamana L; Piris MA; Lopez A
Br J Haematol; 2015 Apr; 169(2):188-98. PubMed ID: 25521006
[TBL] [Abstract][Full Text] [Related]
8. Fine needle aspiration biopsy of a cutaneous relapse of lymphomatoid granulomatosis. A case report.
Vargas J; Arguelles M; Nevado M; de la Serna J; de Agustín P
Acta Cytol; 1993; 37(2):205-8. PubMed ID: 8465642
[TBL] [Abstract][Full Text] [Related]
9. Lymphomatoid granulomatosis. A case for aggressive therapy.
Jenkins TR; Zaloznik AJ
Cancer; 1989 Sep; 64(6):1362-5. PubMed ID: 2475241
[TBL] [Abstract][Full Text] [Related]
10. [Preliminary outcome for patients with relapsed or resistant advanced non-Hodgkin's lymphoma treated by EPOCH regimen].
Huang HQ; Jiang WQ; Wang W; Zhou ZM; Xia ZJ; Lin XB; Li YH; Xu RH; Zhang L; Xu GC; Sun XF; Liu DG; He YJ; Guan ZZ
Ai Zheng; 2003 Apr; 22(4):389-92. PubMed ID: 12703995
[TBL] [Abstract][Full Text] [Related]
11. Angiocentric lymphomatoid granulomatosis and severe hypogammaglobulinaemia.
Váróczy L; Gergely L; Szakáll S; Illés A
Haematologia (Budap); 2002; 32(4):535-41. PubMed ID: 12803130
[TBL] [Abstract][Full Text] [Related]
12. Lymphomatoid granulomatosis with pulmonary and gastrointestinal involvement.
Kappen JH; van Zaanen HC; Snelder SM; van Tilburg AJ; Rudolphus A
BMJ Case Rep; 2017 Feb; 2017():. PubMed ID: 28167690
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of lymphomatoid granulomatosis using cyclosporin-A after failure of intensive chemotherapy.
Raez LE; Temple JD; Saldana M
Am J Hematol; 1996 Nov; 53(3):192-5. PubMed ID: 8895691
[TBL] [Abstract][Full Text] [Related]
14. Defining the cost of cure: infertility among female survivors of lymphoma.
Stern CJ; Seymour JF
Leuk Lymphoma; 2006 Apr; 47(4):574-5. PubMed ID: 16886268
[No Abstract] [Full Text] [Related]
15. DA-EPOCH-R therapy for high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements in a patient with renal dysfunction.
Mitobe M; Kawamoto K; Suzuki T; Suwabe T; Shibasaki Y; Masuko M; Inoue K; Miyoshi H; Ohshima K; Sone H; Takizawa J
J Clin Exp Hematop; 2021 Mar; 61(1):42-47. PubMed ID: 33551436
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous lesions of lymphomatoid granulomatosis.
Brodell RT; Miller CW; Eisen AZ
Arch Dermatol; 1986 Mar; 122(3):303-6. PubMed ID: 3954395
[TBL] [Abstract][Full Text] [Related]
17. Lymphomatoid granulomatosis: a case report with unique clinical and histopathologic features.
Boone JM; Zhang D; Fan F
Ann Clin Lab Sci; 2013; 43(2):181-5. PubMed ID: 23694794
[TBL] [Abstract][Full Text] [Related]
18. Dose-adjusted EPOCH plus rituximab is an effective regimen in patients with poor-prognostic untreated diffuse large B-cell lymphoma: results from a prospective observational study.
García-Suárez J; Bañas H; Arribas I; De Miguel D; Pascual T; Burgaleta C
Br J Haematol; 2007 Jan; 136(2):276-85. PubMed ID: 17233819
[TBL] [Abstract][Full Text] [Related]
19. Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomas.
Roswarski J; Roschewski M; Melani C; Pittaluga S; Lucas A; Steinberg SM; Jaffe ES; Waldmann TA; Wilson WH
Leuk Lymphoma; 2019 Aug; 60(8):2062-2066. PubMed ID: 30626252
[TBL] [Abstract][Full Text] [Related]
20. Successful management with CHOP for pulmonary lymphomatoid granulomatosis in a dog.
Hatoya S; Kumagai D; Takeda S; Yamamoto E; Nakanishi M; Kuwamura M; Sugiura K; Sasai H; Yamate J; Inaba T
J Vet Med Sci; 2011 Apr; 73(4):527-30. PubMed ID: 21139353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
